Internal Medicine, Hematology & Oncology · Wichita, KS
NPI
1932161155
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
818 N Emporia St Ste 403
Wichita, KS, 67214
Phone (316) 262-4467
Groups this clinician bills Medicare through
Medicare paid, 2024
$10.3M
571,786 services
Medicare patients, 2024
1,908
Average age 75
Drug cost, 2024
$5.8M
4,234 prescriptions
Company payments, 2025
$24K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pavan S Reddy was code Q5110 (injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram), 55,740 times for 51 patients. In total Pavan S Reddy billed 571,786 services in 236 codes, and Medicare paid $10.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-02.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 55,740 | 51 | $0.22 | $12K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 51,005 | 41 | $2.33 | $119K |
| J9299 Injection, nivolumab, 1 mg | Office | 50,040 | 28 | $24.61 | $1.2M |
| J9271 Injection, pembrolizumab, 1 mg | Office | 43,000 | 51 | $44.78 | $1.9M |
| J0185 Injection, aprepitant, 1 mg | Office | 31,330 | 96 | $1.34 | $42K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 28,260 | 34 | $39.14 | $1.1M |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 22,440 | 27 | $0.27 | $6,042 |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 18,800 | 84 | $4.43 | $83K |
| J0897 Injection, denosumab, 1 mg | Office | 18,420 | 92 | $20.56 | $379K |
| J9267 Injection, paclitaxel, 1 mg | Office | 16,616 | 31 | $0.08 | $1,342 |
| J9264 Injection, paclitaxel protein-bound particles, 1 mg | Office | 16,300 | 16 | $10.75 | $175K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 15,000 | 15 | $0.87 | $13K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 13,500 | 20 | $0.06 | $753 |
| J1930 Injection, lanreotide, 1 mg | Office | 11,940 | 26 | $38.46 | $459K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 7,920 | 28 | $21.04 | $167K |
By year: 2022 $7.9M for 420,127 services; 2023 $9.2M for 470,076 services; 2024 $10.3M for 571,786 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,759 | 693 | $8.64 | $24K |
| 85027 Blood Count | 2,591 | 692 | $6.33 | $16K |
| 85007 Blood Count | 2,589 | 692 | $3.71 | $9,616 |
| 80053 Clinical Chemistry | 2,346 | 629 | $10.34 | $24K |
| 84443 Clinical Chemistry | 272 | 84 | $16.46 | $4,477 |
| 82728 Clinical Chemistry | 212 | 123 | $13.26 | $2,811 |
| 83550 Clinical Chemistry | 210 | 122 | $8.51 | $1,786 |
| 83540 Clinical Chemistry | 210 | 122 | $6.29 | $1,321 |
| 83615 Clinical Chemistry | 209 | 103 | $5.90 | $1,233 |
| 84153 Clinical Chemistry | 156 | 61 | $18.02 | $2,811 |
Medicare prescription drug claims, 2024
In 2024, the drug Pavan S Reddy prescribed most often to Medicare patients was Anastrozole, with 572 prescriptions and refills. In total Pavan S Reddy wrote 4,234 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 572 | 1,232 | 135 | $6,568 |
| Acyclovir Generic | 319 | 440 | 58 | $5,716 |
| Prednisone Generic | 232 | 282 | 89 | $641 |
| Levothyroxine Sodium Generic | 219 | 366 | 37 | $1,787 |
| Gabapentin Generic | 146 | 203 | 36 | $1,238 |
| Eliquis Apixaban | 139 | 176 | 28 | $101K |
| Dexamethasone Generic | 130 | 215 | 53 | $1,659 |
| Potassium Chloride Generic | 124 | 173 | 52 | $1,112 |
| Allopurinol Generic | 120 | 192 | 34 | $603 |
| Alendronate Sodium Generic | 120 | 278 | 34 | $773 |
| Prochlorperazine Maleate Generic | 113 | 113 | 85 | $2,292 |
| Tamoxifen Citrate Generic | 97 | 265 | 31 | $2,316 |
| Exemestane Generic | 95 | 145 | 18 | $10K |
| Ondansetron Hcl Generic | 94 | 94 | 56 | $1,259 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 79 | 79 | 34 | $2,053 |
Brand drugs: 785 claims; generic drugs: 3,449 claims; opioid claims: 244.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pavan S Reddy $24K ($24K in general payments such as food, travel and fees) from 34 companies. The largest payer was Jazz Pharmaceuticals Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 5 | $12K |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $5,808 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $3,569 |
| Geron Corporation GERN | 1 | $1,200 |
| Pfizer Inc. PFE | 18 | $274 |
| Abbvie Inc. ABBV | 14 | $233 |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $175 |
| Intuitive Surgical, Inc. ISRG | 1 | $118 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $93.83 |
| Daiichi Sankyo Inc. 4568.T | 3 | $55.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.